PERKINS DISCOVERY FUND
Schedule of Investments
June 30, 2025 (unaudited)
92.23% COMMON STOCKS
17.74% BIOTECHNOLOGY
Elutia, Inc.(A)
MDxHealth SA(A)
Veracyte, Inc.(A)
Vericel Corp.(A)
9.96% CONSUMER DISCRETIONARY
Magnite, Inc.(A)
Perion Network Ltd.(A)
1.43% FINANCIALS
FlexShopper, Inc.(A)
9.17% HEALTH CARE DRUGS/SERVICES
ANI Pharmaceuticals, Inc.(A)
NeoGenomics, Inc.(A)
3.92% HEALTH CARE MANUFACTURING
AtriCure, Inc.(A)
14.22% HEALTH CARE SUPPLIES
Axogen, Inc.(A)
BioLife Solutions, Inc.(A)
Exagen, Inc.(A)
TELA Bio, Inc.(A)
9.00% HEALTH CARE SUPPORT
Natera, Inc.(A)
Rockwell Medical, Inc.(A)
Shares |
|
Value |
42,500 |
$ |
84,150 |
32,500 |
|
71,825 |
16,500 |
|
445,995 |
12,000 |
|
510,600 |
|
|
1,112,570 |
20,000 |
|
482,400 |
14,000 |
|
142,100 |
|
|
624,500 |
75,000 |
|
90,000 |
6,350 |
|
414,338 |
22,000 |
|
160,820 |
|
|
575,158 |
7,500 |
|
245,775 |
32,500 |
|
352,625 |
12,500 |
|
269,250 |
16,500 |
|
115,170 |
80,000 |
|
155,200 |
|
|
892,245 |
3,250 |
|
549,055 |
18,181 |
|
15,417 |
|
|
564,472 |
PERKINS DISCOVERY FUND
Schedule of Investments
June 30, 2025 (unaudited)
5.20% HEALTH CARE TECHNOLOGY
Butterfly Network, Inc.(A)
OptimizeRX Corp.(A)
Tactile Systems Technology, Inc.(A)
9.32% INFORMATION TECHNOLOGY
Airgain, Inc.(A)
Digi International, Inc.(A)
Inuvo, Inc.(A)
12.27% SOFTWARE SERVICES
Asure Software, Inc.(A)
Backblaze, Inc.(A)
ePlus, Inc.(A)
92.23% TOTAL COMMON STOCKS
6.24% MONEY MARKET FUND
Fidelity Government Portfolio(A) 4.230%(B)
98.47% TOTAL INVESTMENTS
1.55% Other assets, net of liabilities
100.00% NET ASSETS
(A)Non-income producing
(B)Effective 7 day yield as of June 30,2025
In accordance with U.S. GAAP, "fair value" is defined as the price that a Fund would receive upon selling an investment in an orderly transaction to an independent buyer in the principal or most advantageous market for the investment. Various inputs are used
in determining the value of a Fund’s investments. U.S. GAAP established a three-tier hierarchy of inputs to establish a classification of fair value measurements for disclosure purposes. Level 1 includes quoted prices in active markets for identical securities. Level 2 includes other significant observable inputs (including quoted
Shares |
|
Value |
35,500 |
$ |
71,000 |
14,000 |
|
189,000 |
6,500 |
|
65,910 |
|
|
325,910 |
14,500 |
|
60,175 |
9,000 |
|
313,740 |
45,750 |
|
210,450 |
|
|
584,365 |
25,000 |
|
244,000 |
30,000 |
|
165,000 |
5,000 |
|
360,500 |
|
|
769,500 |
|
|
5,784,495 |
391,166 |
|
391,166 |
|
|
6,175,661 |
|
|
96,997 |
|
$ |
6,272,658 |
prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
Level 3 includes significant unobservable inputs (including the Fund’s own assumptions in determining fair value of investments).
The inputs or methodology used for valuing securities are not necessarily an |
|
|
|
|
|
|
||
indication of the risk associated with investing in those securities. |
|
|
|
|
|
|
||
The following summarizes the inputs used to value the Fund’s investments as of June 30, 2025: |
|
|
|
|
||||
|
|
Level 1 |
|
Level 2 |
|
Level 3 |
|
|
|
|
|
|
Other |
|
Significant |
|
|
|
|
|
Significant |
Unobservable |
|
|
||
|
|
Quoted Prices |
Observable Inputs |
|
Inputs |
|
Total |
|
COMMON STOCKS |
$ |
5,784,495.00 |
$ |
- |
$ |
- |
$ |
5,784,495.00 |
MONEY MARKET FUND |
$ |
391,166.00 |
$ |
- |
$ |
- |
$ |
391,166.00 |
TOTAL INVESTMENTS |
$ |
6,175,661.00 |
$ |
- |
$ |
- |
$ |
6,175,661.00 |
The cost of investments for Federal income tax purposes has been estimated a/o June 30, 2025 since |
|
|
|
|
||||
the final tax characteristics cannot be determined until fiscal year end. Cost of securities for Federal income |
|
|
|
|
||||
tax purpose is $3,856,270, and the related net unrealized appreciation (depreciation) consists of: |
|
|
|
|
||||
|
|
|
|
Gross unrealized appreciation |
$ |
3,272,454 |
||
|
|
|
|
Gross unrealized depreciation |
|
(953,063) |
||
|
|
|
|
Net unrealized appreciation |
$ |
2,319,391 |
||